James Rolke
Chief Executive Officer at Revelation Biosciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Revelation Biosciences Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Revelation Biosciences Inc. May 15, 202483.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Revelation Biosciences Inc. | Grant or award | +208,076 | — | — |
| Apr 30, 2026 | Revelation Biosciences Inc. | Shares withheld for tax | −10,115 | $1.13 | $11,430 |
| Feb 3, 2026 | Revelation Biosciences Inc. | Shares withheld for tax | −8,521 | $1.86 | $15,849 |
| Jan 8, 2026 | Revelation Biosciences Inc. | Grant or award | +532,829 | $0.90 | $479,546 |
| Oct 29, 2025 | Revelation Biosciences Inc. | Grant or award | +390,614 | $1.28 | $499,986 |
| Feb 11, 2025 | Revelation Biosciences Inc. | Grant or award | +30,095 | $3.87 | $116,468 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.